Objectives of Study:
|
1.Evaluate the efficacy of Fuyanxiao capsule combined with antibiotics on pelvic inflammatory diseases on the basis of reducing the amount of antibiotics used, and optimize the clinical program for the treatment of pelvic inflammatory diseases with integrated Chinese and Western medicine;
2.To evaluate the effect of Fuyanxiao Capsule combined with antibiotics in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome) on McCormack scale scores, TCM syndromes, pelvic mass and fluid accumulation;
3.Explore the effect of Fuyanxiao capsule combined with antibiotics in reducing the incidence of sequelae of pelvic inflammatory diseases;
4.To evaluate the safety of the clinical application of Fuyanxiao capsule combined with antibiotics in the treatment of pelvic inflammatory diseases (damp-heat stasis syndrome).
|
Inclusion criteria
|
For a qualified subject, the answer to all the selection criteria must be "yes".
1.Meet the diagnostic criteria of Western medicine for pelvic inflammatory diseases;
2.Patients who meet the TCM syndrome of damp-heat stasis;
3.Aged 20 to 50 years, married or have a history of sexual life;
4.4<McCormack score <=12 points when entering the group;
5.Lower abdominal pain VAS >= 4 points;
6.Axillary body temperature<=38.0℃;
7.The patient himself gave informed consent and signed the informed consent form.
|
Exclusion criteria:
|
For a qualified subject, the answer to all exclusion criteria must be "No":
1.Combined with medical history and physical signs, auxiliary examinations include appendicitis, ectopic pregnancy, torsion of ovarian cyst pedicle, pelvic hemorrhage, rupture of ovarian cyst, gastroenteritis, sequelae of pelvic inflammatory disease, endometriosis, adenomyosis And related symptoms caused by Neisseria gonorrhoeae infection;
2.Patients are pregnant, lactating or planning to become pregnant in the near future;
3.Routine blood white blood cell count> 1.1 times the upper limit of normal, and blood routine neutrophil percentage> 90%;
4.Patients are in critical condition or have surgical indications, such as complicated fallopian tube ovarian abscess, pelvic abscess, diffuse peritonitis, sepsis, etc.;
5.Patients with serious primary diseases and mental illnesses of the heart, brain, liver, kidney, hematopoietic and immune systems;
6.Patients have taken relevant Chinese and Western medicines for the treatment of this disease within 1 month before enrollment, and the curative effect of the medicine is difficult to judge;
7.Patients are allergic to the drug components of the known test drugs;
8.Alanine aminotransferase (ALT), aspartate aminotransferase (AST) greater than 1.2 times the upper limit of normal, and blood creatinine (Cr) greater than the upper limit of normal;
9.Participate in other clinical studies within 1 month before screening.
|